ATF3 and colitis: Collectively, the observations that DSS treatment in ATF3−/− mice introduced more mucosal epithelial damage, extensive inflammation, loss of epithelial architecture, loss of crypts, and enhanced immune cell infiltrates, provide evidence that ATF3 is a pillar base for a balanced intestinal stress response to maintain mucosal integrity during colitis.